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Abstract
Infections with intracellular bacteria such as chlamydiae affect the majority of the world population. Infected tissue
inflammation and granuloma formation help contain the short-term expansion of the invading pathogen, leading also to
local tissue damage and hypoxia. However, the effects of key aspects of damaged inflamed tissues and hypoxia on
continued infection with intracellular bacteria remain unknown. We find that development of Chlamydia trachomatis is
reversibly retarded by prolonged exposure of infected cells to extracellular adenosine, a hallmark of hypoxia and advanced
inflammation. In epithelial cells, this effect was mediated by the A2b adenosine receptor, unique in the adenosine receptor
family for having a hypoxia-inducible factor (HIF1-a) binding site at its promoter region, and was dependent on an increase
in the intracellular cAMP levels, but was independent of cAMP-dependent protein kinase (PKA). Further study of adenosine
receptor signaling during intracellular bacterial infection could lead to breakthroughs in our understanding of persistent
infections with these ubiquitous pathogens.
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Introduction
Chlamydia trachomatis species are the leading cause of bacterial
sexually transmitted infection and preventable blindness [1].
Chlamydiae are obligate intracellular bacteria which mature and
reproduce through a unique biphasic developmental cycle,
infecting as metabolically inactive elementary bodies (EBs) and
maturing into metabolically active but non-infectious reticulate
bodies (RBs), which proliferate before condensing back into
infectious EBs to complete the cycle [2–4]. Much of the pathology
caused during Chlamydia infection is due to the inflammatory
response it invokes from the host. The initial innate immune
response recruits inflammatory cells and T cells necessary for
resolution of infection, which depends heavily on production of IL-
12 and IFN-c [5]. Besides the dominant role of IFN-c and a TH1
response for clearance of infection in vivo, IFN-c has been
implicated in the development of persistent Chlamydia infection in
vitro [6], while other factors that could contribute to persistent
pathogenic infection may be released from the infected tissue
rather than uninfected immune cells.
Adenosine has been suggested to function as a ‘STOP’ signal for
the immune response during excessive inflammatory conditions
which threaten not only the pathogen, but also the infected or
neighboring tissues [7]. Extracellular adenosine signals through
four characterized adenosine receptors (ARs) – A1, A2a, A2b and
A3 – of which only the A2b AR is upregulated during hypoxia [8].
In fact, A2b contains a hypoxia inducible factor (HIF-1a) binding
site in its promoter region [9], suggesting that A2b may play a key
role in the response to extracellular adenosine under hypoxic
conditions, whereas the A2a AR may dominate the response
during inflammation in the absence of hypoxia. While increasing
attention has been paid to the effects of extracellular adenosine on
the inflammatory response [7,10], no studies have been performed
to evaluate the possible effects of adenosine directly on the infected
cell or on latency of infection. We therefore investigated a key
aspect of inflammation and hypoxia, prolonged exposure to
extracellular adenosine on infection by an intracellular pathogen,
C. trachomatis (Figure S1).
Results
To test whether adenosine exposure could affect the outcome of
C. trachomatis infection in epithelial cells, we first measured the
response to 59-(N-ethylcarboxamido) adenosine (NECA), which
stimulates Gs-coupled ARs. Cervical epithelial cells (HeLa 229)
infected with C. trachomatis serovar LGV L2 were treated with
NECA, which caused a 90% reduction in reinfectious chlamydiae
within a few hours of addition. However, reinfectious bacteria
recovered to levels of untreated host-cells by the end of the
developmental cycle (Figure S2). This suggests that chlamydial
development was substantially interrupted for short times after Gs-
coupled AR stimulation, but that the effect was reversible, since
chlamydial viability was not significantly affected.
Cyclic AMP (cAMP) levels were measured in HeLa cells in
response to adenosine alone, or adenosine added after an inhibitor
of adenosine deaminase, erythro-9-(2-hydroxy-3-nonyl) adenine
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minutes of adenosine stimulation, and remained elevated in the
presence of EHNA, whereas cAMP levels receded back to the level
of unstimulated cells six hours in the absence of adenosine
deaminase inhibition (Figure S3). Thus Gs-coupled, and not Gi-
coupled, adenosine receptor stimulation dominates during expo-
sure to 50 mM adenosine in HeLa cells. The expression of all four
adenosine receptors in HeLa cells was confirmed by PCR, which
showed, among the Gs-coupled receptors, markedly higher levels
of A2b than A2a (Figure S4).
To investigate the outcome of C. trachomatis infection in
epithelial cells during prolonged exposure to adenosine, we
treated epithelial cells with EHNA before addition of adenosine.
Synergistic and concentration-dependent effects of EHNA and
adenosine co-incubation on infected epithelial cells resulted in
$90% or greater reduction in the yield of reinfectious
chlamydiae at moderate adenosine concentrations (50 mM)
(Figure 1A). Similar results were also achieved during infection
with the more clinically-prevalent C. trachomatis serovar D
(Figure S5).
To identify the specific Gs-coupled ARs involved in adenosine-
mediated inhibition of chlamydial development, shRNA-encoding
lentiviruses targeting the two human Gs-coupled ARs, A2a and
A2b, were used for depleting the receptors in epithelial cells. Cells
depleted of A2b mRNA allowed significantly more robust
chlamydial growth in the presence of EHNA and adenosine,
compared to control cells transduced with non-targeted shRNA-
encoding lentiviruses. In a representative experiment, the
reinfectious yield more than doubled in A2b-depleted cells
(Figure 1B). In contrast, A2a depletion did not enhance chlamydial
growth during extended adenosine exposure. mRNA quantifica-
tion by qPCR was used to verify greater than 50% mRNA
reduction for each target AR in each depletion experiment,
performed separately on three occasions.
Additionally, administration of adenosine alone (100 mM)
repeatedly led to a greater than 80% reduction in C. trachomatis
16s rRNA generation by 24 hours post-infection (hpi) compared to
controls, which received vehicle alone over the same time period
(Figure 2). Thus prolonged exposure to extracellular adenosine
dramatically altered the growth of Chlamydia in epithelial cells.
Significant reductions were also achieved over this time course
using a cell-permeable cAMP analog, 8-bromoadenosine-39,5 9-
cyclic monophosphate (8-Br-cAMP), or forskolin (FSK), an
activator of adenylyl cyclase (Figure 2), suggesting that intracellular
cAMP increase downstream of adenosine receptor ligation is
responsible for the effects on chlamydial development. Pretreat-
ment of host cells with cell-permeant cAMP analogs before
infection had previously been reported to reduce uptake of C.
trachomatis [11], although the receptor stimulated was not
determined. However, treatment with 8-Br-cAMP starting at 1
hpi did not reduce the percentage of inclusion-bearing cells (data
not shown).
Host responses resulting from an increase in the intracellular
cAMP concentration are often mediated by cAMP-dependent
protein kinase (PKA). We therefore depleted HeLa cells of the
catalytic subunit of PKA (PKA C-a) using siRNA, and evaluated
whether diminished chlamydial growth due to adenosine treat-
ment was dependent on this signaling pathway. In cells with
significantly reduced levels of PKA C-a mRNA (Figure S6),
prolonged exposure to adenosine diminished chlamydial develop-
ment as effectively as in cells treated with non-targeted siRNA
(Figure 3A), suggesting a PKA-independent mechanism for
adenosine-induced growth retardation of C. trachomatis. Depletion
of PKA C-a protein in HeLa cells was also confirmed by Western
blot (Figure 3B); and pharmacological inhibition of PKA with N-
[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide
(H89) did not alter the functional response to adenosine with
respect to infection (data not shown).
Figure 1. Extended exposure to extracellular adenosine (ADO) causes a dose-dependent reduction in chlamydial development via
the A2b adenosine receptor. (A) HeLa cells were infected with C. trachomatis serovar L2 at an MOI of 1, followed by treatment with the adenosine
deaminase inhibitor, EHNA, and ADO at indicated concentrations at 1 and 20 hours post infection (hpi). Samples were harvested at 42 hpi for
quantification of reinfectious yield (IFU/ml) on new cell monolayers. The values show averages and S.D. from 3 samples of a representative
experiment, and give results obtained from three independent experiments. (B) HeLa cell knock-downs (KDs) were produced with non-targeted
(Control), A2a-targeted (A2a KD) or A2b-targeted (A2b KD) shRNA and levels of target KD verified to be decreased at least 50% by qPCR. Cells were
infected and harvested as (A), with treatment of 25 mM EHNA and 50 mM ADO at 1 and 20 hpi. The values shown are averages and S.D. of values from
4 independent experiments. (n=4, *, P,0.05, for treated cells in A2b KD compared to nontarget control.)
doi:10.1371/journal.pone.0008299.g001
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eukaryotic but not prokaryotic protein synthesis, could prevent the
effect of adenosine of chlamydial development. Cycloheximide at
1 mg/ml, which enhances slightly chlamydial development under
normal infection conditions, did not allow significantly more
production of chlamydial 16s rRNA during treatment with
adenosine (Figure S7), suggesting that production of new host-
cell protein does not play a major role in the observed limitation of
chlamydial development.
To show that reduction in growth was not due to death of the
chlamydiae, infected cells were treated with EHNA and adenosine
for extended periods of time. Lower levels of reinfectious
chlamydiae were harvested following these conditions; however,
removal of EHNA and adenosine and replenishment with cell-
culture medium allowed rapid recovery of chlamydial 16s rRNA
production (Figure 4) and reinfectious bacteria (Figure S8).
Chlamydial 16s rRNA generation is higher for metabolically
active RBs compared to EBs, and moderate levels of 16s rRNA at
late time points, along with more significantly diminished
reinfectious yield, indicates enduring chlamydial activity with
incomplete development for samples with continued exposure to
adenosine.
Fluorescence microscopy of EHNA and adenosine-stimulated
C. trachomatis-infected cells revealed inclusions which were
consistently smaller than those in untreated cells, and were
largely devoid of chlamydial bodies (Figure 5). Acridine orange
staining allows differentiation of chlamydial populations as
primarily RBs (RNA:DNA ratio 3:1) or primarily EBs
(RNA:DNA ratio 1:1), with a peak emission in green when
bound to DNA and red when bound to RNA [12], and also
observation of the localization of RBs and EBs. In the absence of
treatment, chlamydiae are rich in DNA (mostly EBs) at 42 hpi,
and are found mostly within the inclusions, consistent with other
studies [13] (Figure 5A). However, chlamydial populations in
infected cells treated with EHNA and adenosine consisted of small
numbers of RNA-rich RBs, as well as some EBs, scattered along
the periphery of the inclusions (Figure 5B). This inclusion
morphology was ubiquitous. It has been previously shown that
IFN-c, an inducer of a persistence-like phenotype in vitro,
Figure 2. Repeated exposure to cell permeable cAMP analog or
cAMP elevating agents causes a reduction in chlamydial
development. HeLa cells were infected with C. trachomatis serovar
L2 at an MOI of 1, followed by treatment with adenosine (100 mM),
forskolin (FSK, 10 mM), or 8-Br-cAMP (100 mM) starting at 1 hour post
infection (hpi) every half-hour through 6 hpi (10 additions). Total RNA
was harvested at 24 hpi for quantification of chlamydial 16s rRNA
production using qPCR as indicated in methods. The values shown are
relative to control values for each experiment, and are averages and
S.D. from 3 independent experiments. (n=3, **, P,0.0005, ***,
P,0.0001 for treated cells compared to untreated control.)
doi:10.1371/journal.pone.0008299.g002
Figure 3. Effects of adenosine on C. trachomatis growth are
independent of PKA. (A) HeLa cells were transfected PKA C-a
targeted siRNA, then infected 30 hours post transfection with C.
trachomatis, and treated with EHNA (25 mM) and adenosine (50 mM) 1
hpi. Total RNA was harvested at 24 hpi for quantification of chlamydial
16s rRNA production using qPCR as indicated in Materials and Methods.
The values shown are relative to control values for each experiment,
and are averages and S.D. from 3 independent experiments. (B) Western
blot confirmation of PKA C-a depletion by PKA siRNA but not nontarget
siRNA. Western blot was performed twice on two separate cell samples.
doi:10.1371/journal.pone.0008299.g003
Figure 4. Exposure to adenosine induces a reversible block in
chlamydial development. HeLa cells were infected with C.
trachomatis serovar L2 at an MOI of 1, followed by treatment with an
equivalent volume of vehicle alone (control) or 25 mM EHNA and 50 mM
adenosine at 1 hpi (non-control samples), 24 hpi (48hpi recovery; and
Continuous Ado), and 48 hpi (Continuous Ado only). Media was
refreshed in all samples at 24 and 48 hpi, and EHNA and adenosine
added again to the samples indicated. Total RNA was harvested at 24
hpi for quantification of chlamydial 16s rRNA production using qPCR as
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comparison (Figure 5C), acridine orange staining shows that
inclusions in Chlamydia-infected cells treated with IFN-c were
stochastically reduced in size, and were also primarily filled with
RBs, some of larger ‘‘aberrant’’ size, as has been reported.
Differences in ultrastructural observations of Chlamydia during
variously induced persistent conditions have been noted
previously [14]. A large inclusion containing both opaque RBs
(1 mm) and smaller, darker EBs (0.3 mm) are observed by
transmission electron microscopy in untreated cells infected
with C. trachomatis (Figure 5D). However, inclusions in EHNA-
and adenosine-treated cells contained sparsely-populated inclu-
sions (Figure 5E).
Discussion
Bacterial persistence has been studied in varied circumstances
[15,16], but may have unique characteristics for intracellular
bacterial pathogens [14,17]. Pathogens which are obligately
intracellular typically have significantly reduced genome size and
would be expected to have a lower capacity to withstand
disruptions to their microenvironment, possibly developing
alternate growth or subsistence mechanisms. Many alterations to
the microenvironment during chlamydial infection lead to the
initiation of a persistence program during which the chlamydiae
experience severely diminished growth and modifications of both
bacterial and inclusion development, although causative stimulants
and the ultrastructural manifestations can vary [14].
One mode of sequestration from the adaptive immune response
is the formation of granulomas in the host tissue, which may be
initiated or altered by the pathogen [18]. Granulomas are typically
observed during C. trachomatis infection, and become more
abundant under conditions where inflammation is enhanced
[19]. Notably, granulomas were absent following chlamydial
infection of IL-10 knockout mice which had a more dominant
TH1 type immune cell response than wild-type mice [20]. During
sequestration within granulomas, the bacteria may not have
sufficient nutrient accessibility for growth, being isolated from
substantial blood flow under tissue conditions which have been
shown to be hypoxic during infections with another intracellular
pathogen, Mycobacterium tuberculosis [21,22], which affects not only
replicative capacity but also sensitivity to different modes of
antimicrobial therapy.
Members of the AR family have been shown to play critical
roles in the host response to microbial pathogens [7,9,23]. The
A2a AR has been well studied in the context of being the
dominant receptor in the behavioral response to caffeine, and for
its role in regulation of immune function and inflammation where
adenosine serves as a ‘danger signal’ [7]. The A2b AR has a lower
affinity for adenosine relative to A2a which suggests that A2b
should function in areas of increased adenosine concentration.
Responses to adenosine in epithelial cells, including primary
epithelial cells [24], have been previously characterized, with both
A2a [25] and A2b [26] contributing to cell responses depending
on tissue type.
While an increase in the intracellular cAMP concentration led
to diminished growth of C. trachomatis in epithelial cells, this was
not mediated by cAMP-dependent protein kinase (PKA). Other
signaling pathways dependent on cAMP, but independent of
PKA, have been characterized and can be activated following
A2b stimulation, including cAMP-stimulated GDP exchange
factor (EPAC1 and EPAC2) pathways [27]. The A2a adenosine
receptor acts almost exclusively through cAMP modification, but
the A2b receptor can also stimulate phospholipase C (PLC), and
phosphoinositide 3-kinase (PI3K), which may contribute to the
effects characterized here [28,29]. Future work will further
identify the downstream mediators of the cAMP-dependent,
PKA-independent pathway responsible for chlamydial growth
inhibition.
The A2b AR is upregulated during hypoxia, and has an HIF-
1a binding site in its promoter region [9]. C. pneumoniae has been
shown to directly disrupt function of HIF-1a during infection of
epithelial cells in vitro [30], which indicates that this lung
pathogen may attempt to counteract the effects of A2b
expression in actively infected cells. However, this also suggests
that hypoxia has been an important obstacle for C. pneumoniae
survival, given that the minimalist genome of Chlamydia species
maintains a commitment to specific disruption of this signaling
pathway.
AR signaling, particularly through the A2b receptor, may play
an important role in disease progression or abrogation during
infections that result in local hypoxia, such as in granulomas
caused by chlamydial infection [19]. Clarification of the role
played by adenosine-mediated signaling may thus shed light on the
mechanisms underlying persistence during infection with Chlamydia
and other intracellular pathogens.
Figure 5. Extended exposure to adenosine causes modification
of Chlamydia inclusions, tending to moderately sized inclusions
with few chlamydiae, compared to smaller-sized inclusions
with larger chlamydial forms following treatment with IFN-c.
HeLa cells were infected with C. trachomatis serovar L2 at an MOI of 1.0.
Samples were (A, D) untreated, (B, E) treated with 25 mM EHNA and
50 mM ADO at 1 and 20 hpi, or (C) treated with 5 ng/ml IFN-c at 1 hpi.
Staining with Acridine Orange was performed as described in Methods
with fixation at 42 hpi. Red staining corresponds to RNA localization,
while green staining corresponds to DNA. Arrows, Chlamydia inclusion;
arrowheads, host-cell nuclei. Representative of three experiments, scale
bars 10 mm. Electron microscopy samples were also fixed at 42 hpi and
prepared for transmission electron microscopy as described in
supporting material. Scale bars, 5 mm.
doi:10.1371/journal.pone.0008299.g005
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Cells, Bacteria, and Reagents
HeLa229 cells (American Type Culture Collection, Manassas,
VA) were cultured in a humidified incubator at 37uC with 5%
CO2 in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 10% heat-inactivated fetal calf serum. The LGV/L2
strain of C. trachomatis was from Dr. Roger Rank (University of
Arkansas, Little Rock, AR), and C. trachomatis serovar D was from
Dr. David Nelson (Indiana University, Bloomington, IN).
Adenosine (ADO), 59-(N-ethylcarboxamido)adenosine (NECA),
erythro-9-(2-Hydroxy-3-nonyl) adenine (EHNA), 8-bromoadeno-
sine-39,5 9-cyclic monophosphate (8-Br-cAMP), cycloheximide,
and forskolin (FSK) were from Sigma (St. Louis, MO).
Cell Culture and Infection
HeLa cells growing at 70% confluence in tissue culture plates
(Costar) were infected with the LGV/L2 or D serovars (as
indicated) of C. trachomatis at a multiplicity of infection (MOI) of
1.0, unless otherwise noted, and incubated at 37uC under 5% CO2
with treatments and media changes at the indicated times. The
number of infectious chlamydial inclusion forming units was
determined as previously described [31]. In brief, material from
HeLa cells infected under different conditions and times was
harvested from wells using a cell scraper, frozen at 280uC, thawed
and thoroughly vortexed before titrating on 50% confluent HeLa
cells for quantification by light microscopy or immunofluorescence
on a widefield fluorescence microscope (Leica, Deerfield, IL,
USA). Cells were stained with C. trachomatis genus antibodies from
Argene (North Massapequa, NY), as described.
cAMP Measurement
Intracellular cAMP levels were evaluated using a direct cAMP
enzyme immunoassay (Assay Designs, Ann Arbor, MI), per the
manufacturer’s recommendations, including optional acytelation
of samples.
shRNA
MISSIONH shRNA Lentiviral Transduction Particles for human
A2a and A2b ADO receptors, as well as non-targeted shRNA
(SHC002V), were acquired from SigmaAldrich, and used per
manufacturer’s recommendations for adherent cells. HeLa cells
were transduced separately with each construct per the manufac-
turer’s recommendations, and selected by addition of puromycin
(Sigma) at 2 mg/ml. Cells expressing each construct were
individually tested by quantitative PCR to evaluate knockdown of
the target genes, and in our hands lentiviral transduction particles
TRCN0000008043 for human A2a and TRCN0000065335 for
A2b ADO receptors were most effective in HeLa cells. Sequences
for these constructs are available from Sigma online.
siRNA
Two sequences of siRNA targeting PKA C-a, and non-targeted
siRNA, were obtained from Cell Signaling Technology (Danvers,
MA), and transfected into HeLa cells using Lipofectamine 2000
(Invitrogen, Carlsbad, CA) per both manufacturers’ recommen-
dations. mRNA depletion (qPCR) and protein depletion (Western
blot) were verified 30 hours post transfection, the time at which
treatment was applied in functional assays.
Western Blotting
Samples were lysed using RIPA Lysis Buffer (Millipore), protein
quantities evaluated by the Bradford assay, and loaded onto SDS-
PAGE 12% gel, and then transferred to a polyvinylidene
difluoride membrane (Millipore). Blots were blocked for 1 h with
5% (w/v) nonfat dried milk in TBST. The membrane was
incubated overnight at 4uC with with rabbit anti-PKA C-a (Cell
Signaling Technology, Danvers, MA) and then incubated again
with conjugated anti-rabbit IgG horseradish peroxidase (Milli-
pore). Immunoreactive proteins were detected with ECL Plus
Western Blotting Detection Reagents (Amersham) using a gel doc
system (Biorad).
Microscopy
For Acridine Orange staining, cells were fixed in acid alcohol (1
part glacial acetic acid, and 1 part absolute ethanol (Fisher
Scientific)) for 10 minutes, and then rinsed 3 times with McIlvaines
buffer (pH 3.8, 18.7 g Na2HPO4-7H2O,13.9 g citric acid-H2O,
water to 200 ml). Coverslips with fixed cells were then stained with
0.01% Acridine Orange (Molecular Probes, Eugene, OR) for 4
minutes, washed 3 times with McIlvaines buffer. Slides were
viewed on the widefield fluorescence microscope. For electron
microscopy cell samples, HeLa cells growing at 70% confluence in
tissue culture plates (Costar) were infected with the LGV/L2 strain
of C. trachomatis at an MOI of 1.0 and incubated at 37uC under 5%
CO2 with treatments and media changes at the indicated times.
The cells were fixed in 2.5% glutaraldehyde (Ted Pella Inc.,
Redding, CA) for 1 hour, rinsed in PBS, then pelleted and
embedded in warm agar. The tissue was then immersed in 4%
OsO4 (Ted Pella) for 1 hour, followed by 3 rinses in PBS. Cell
pellets were stained en bloc with 0.5% uranyl acetate overnight,
then rinsed 3 times in distilled water. The pellets were dehydrated
through a series of ethanol concentrations (25%, 50%, 75%, 95%,
and 100%) for 10 minutes at each concentration, then embedded
in resin (Ted Pella) at 1:2 resin:ethanol overnight, 1:1 resin:ethanol
for 8 hours, 2:1 resin:ethanol overnight, and 100% resin for 8
hours. The tissue was finally moved to new 100% resin in conical
BEEM capsules (Ted Pella) and hardened at 65uC for 24 hours.
Ultra thin sections (90 nm) were obtained using an ultramicrotome
(Power Tome-XL, RML), stained with uranyl acetate and lead
citrate in sequence, and observed with a FEI Tecnai 12
Transmission electron microscope.
RNA Extraction
Total RNA was extracted using TrizolH Reagent (Invitrogen)
following the manufacturer’s instructions. The total RNA was
quantified by measuring the optical density with a NanoDrop ND-
1000 Spectrophotometer (NanoDrop, Wilmington, DE).
cDNA Synthesis
Two mg of total RNA were reverse-transcribed at 42uC using
TaqMan reverse trancriptase (Applied Biosystems) and Oligo(dT)
according to the manufacturer’s recommendations.
Quantitative PCR with SYBR Green
For each transcript, a standard curve was constructed using the
purified PCR product generated for each specific primer pair.
Each PCR reaction utilized BrilliantH SYBRH Green Master Mix
(Stratagene), and consisted of 25 ml containing 1 ml of cDNA and 5
pmol of each primer. A non-template negative control to check for
primer-dimerization was run for each primer pair. The real-time
qPCR was run on an MX3000p (Stratagene). The cycling
conditions were 1 cycle of denaturation at 95uC/10 min, followed
by 40 three-segment cycles of amplification (95uC/30 sec, 55uC/1
min, 72uC/30 sec), where the fluorescence was automatically
measured during PCR and one three-segment cycle of product
Adenosine Inhibits Chlamydiae
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adjustment method of the Mx3000 software was used to determine
the Ct in each reaction. A melting curve was constructed for each
primer pair to verify the presence of one gene-specific peak and
the absence of primer dimerization. All samples were amplified in
triplicates and the mean was used for further analysis. Primer
sequences for the human ADO A2a receptor were: 59-
GGAGTTTGCCCCTTCCTAAG-39, forward primer; and 59-
CTTCTCCCAACGTGACTGGT-39, reverse primer. For the
ADO A2b receptor, the primers were: 59-GCTCCATCTT-
CAGCCTTCTG-39, forward primer; and 59-ACCCAGAGGA-
CAGCAATGAC-39, reverse primer. For C. trachomatis 16s rRNA
the primers were: 59-CCCGAGTCGGCATCTAATAC-39 for-
ward primer, and 59-CTACGCATTTCACCGCTACA-39 re-
verse primer. Human GAPDH was used as the housekeeping gene
control for AR expression analysis, for which the primers were: 59-
CGACCACTTTGTCAAGCTCA-39 forward primer, and 59-
AGGGGAGATTCAGTGTGGTG-39.
Analysis of mRNA Expression for Adenosine Receptors
In order to determine whether HeLa cells express the adenosine
receptor genes (A1, A2a, A2b, A3), PCR amplification was carried
out with primers specific for the human genes. The sequences of
the primers for GAPDH, A2a, and A2b were described in the
qPCR methods, and the A1 and A3 sequences used were as
follows A1, forward primer, 59-TCAGTCCAGTCCTCA-
CATGC -39; reverse primer, 59-GTGGAGGGACCACACTC-
TGT-39 (amplicon expected size, 200 bp); A3, forward primer, 59-
TACTGGTGCCGAGGCTATTT-39; reverse primer, 59-
TGGTCAGGCAGGACATAGTG-39. The PCR cycling protocol
for all primers was 94uC for 30 seconds, 50uC for 30 seconds and
72uC for 30 seconds. The protocol was repeated for 40 cycles and
included an initial 5 min enzyme activation step at 94uC and a
final 10 min extension step at 72uC. PCR products were separated
by electrophoresis on a 2% agarose gel and visualized by ethidium
bromide staining.
Supporting Information
Figure S1 Adenosine is released from hypoxic cells, and
adenosine levels are also elevated by processing of released ATP
from stressed cells (via CD73 and CD39 ecto-enzymes). A2b
receptor expression is also increased in tissues with low oxygen,
mediated by the hypoxia-inducible factor-1alpha (HIF-1alpha)
transcription factor. Ligation of the A2b adenosine receptor during
infection with the intracellular pathogen C. trachomatis causes
reversible inhibition of bacterial development. Exposure to
elevated extracellular adenosine may lead to persistent infections
in vivo.
Found at: doi:10.1371/journal.pone.0008299.s001 (0.10 MB TIF)
Figure S2 Treatment with NECA, an AR agonist, reversibly
inhibits growth of Chlamydia. HeLa cells were infected with C.
trachomatis serovar L2 at an MOI of 1, followed by treatment with an
equivalent volume of vehicle alone (Control) or with 100 uM NECA
at 20 hours post infection (hpi). Samples were harvested at the
indicated times for quantification of reinfectious yield (IFU/ml) on
new HeLa cell monolayers. Treatment with NECA caused a 90% or
greater reduction in reinfectious yield at times shortly after treatment
(25 and 30 hpi), but reinfectious yield was similar in Control and
NECA-treated samples at subsequent timepoints. The values show
averagesandS.D.from3samplesofarepresentativeexperiment,and
represent results obtained from two independent experiments.
Found at: doi:10.1371/journal.pone.0008299.s002 (0.10 MB TIF)
Figure S3 cAMP levels in HeLa cells were evaluated using an
enzyme immunoassay. Cells were treated with 50 uM adenosine
(Ado) in the presence or absence of EHNA (25 uM), as indicated,
over the displayed time-course. Samples were lysed in 0.1 M HCl
with 0.1% Triton X-100, following the manufacturer’s protocol,
which included sample acetylation. The values show averages and
S.D. from 3 independent experiments. (n=3, *, P,0.05, for
EHNA plus adenosine treated cells compared to cells treated with
adenosine alone.)
Found at: doi:10.1371/journal.pone.0008299.s003 (0.06 MB TIF)
Figure S4 Expression of adenosine receptor mRNA in HeLa
cells. PCR was performed as indicated in Materials and Methods.
Expected amplicon sizes were: GAPDH, 203 bp; A1, 121 bp; A2a,
72 bp; A2b, 121 bp; A3, 124 bp. The expression levels are
representative of two experiments prepared from separate cell
samples on separate dates.
Found at: doi:10.1371/journal.pone.0008299.s004 (0.05 MB TIF)
Figure S5 HeLa cells were infected with C. trachomatis serovar D
at an MOI of 1, followed by treatment with an equivalent volume
of vehicle alone (Control) or 25 uM EHNA and 50 uM adenosine
1 hpi. Samples were harvested at 42 hpi for quantification of
reinfectious yield (IFU/ml) on new HeLa cell monolayers.
Prolonged exposure to adenosine caused an 80% or greater
reduction in reinfectious yield. The values show averages and S.D.
from triplicates of a representative experiment, and represent
results obtained from two independent experiments.
Found at: doi:10.1371/journal.pone.0008299.s005 (0.06 MB TIF)
Figure S6 Depletion of PKA C-alpha in HeLa cells. siRNA
targeting PKAC-alpha was transfected into HeLa cells, and mRNA
levels of PKA C-alpha 30 hours post transfection were compared to
nontarget siRNA controls and untreated cells. The values show
averages and S.D. from three independent experiments.
Found at: doi:10.1371/journal.pone.0008299.s006 (0.06 MB TIF)
Figure S7 Effect of extracellular adenosine (Ado) does not
require new host-cell protein synthesis. HeLa cells were infected
with C. trachomatis serovar L2 at an MOI of 1, followed by
treatment as indicated at 1 hpi. Concentrations of reagents were:
cycloheximide, 1 ug/mL; EHNA, 25 uM; adenosine, 50 uM.
Total RNA was isolated at 24 hpi for quantification of chlamydial
16s rRNA production using qPCR as indicated in Materials and
Methods. The values shown are relative to control values and are
representative of two independent experiments.
Found at: doi:10.1371/journal.pone.0008299.s007 (0.07 MB TIF)
Figure S8 Reversible effect of adenosine (Ado) on chlamydial
infection. HeLa cells were infected with C. trachomatis serovar L2 at
an MOI of 1, followed by treatment with an equivalent volume of
vehicle alone (control) or 25 uM EHNA and 50 uM adenosine 1
hpi (treated and recovery). Media was refreshed in all samples at
24 hpi, and EHNA and adenosine added again to the ‘‘treated’’
samples only. Samples were harvested at 44 hpi and 72 hpi for
quantification of reinfectious yield (IFU/ml) on new HeLa cell
monolayers. Reinfectious yield recovered to near control values
within 48 hours of discontinuation of elevated adenosine exposure.
The values show averages and S.D. from triplicates of a
representative experiment, and represent results obtained from
two independent experiments.
Found at: doi:10.1371/journal.pone.0008299.s008 (0.05 MB TIF)
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